Identification of a BRAF/PA28γ/MEK1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis
Abstract Oral submucous fibrosis (OSF) is a chronic and insidious oral potentially malignant disorder associated with a 4–17% risk of oral squamous cell carcinoma (OSCC). Our previous study found that proteasomal activator 28 gamma (PA28γ) is frequently overexpressed in oral squamous cell carcinoma...
Main Authors: | Changqing Xie, Zaiye Li, Yufei Hua, Silu Sun, Liang Zhong, Qian Chen, Hui Feng, Ning Ji, Taiwen Li, Xikun Zhou, Xin Zeng, Zhangui Tang, Chongkui Sun, Jing Li, Qianming Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-08-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05152-6 |
Similar Items
-
PA28γ, an Accomplice to Malignant Cancer
by: Kexin Lei, et al.
Published: (2020-10-01) -
Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma
by: Jessie Villanueva, et al.
Published: (2013-09-01) -
PA28γ induces dendritic cell maturation and activates T‐cell immune responses in oral lichen planus
by: Yimei Wang, et al.
Published: (2024-05-01) -
Immunological effects of BRAF+MEK inhibition
by: Paolo A. Ascierto, et al.
Published: (2018-09-01) -
Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses
by: Jing Li, et al.
Published: (2015-08-01)